Associated Papers
Effect of donor GSTM3 rs7483 genetic variant on tacrolimus elimination in the early period after liver transplantation.
Zhang T et al.
Peerj, 2024
Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles.
Chamboko CR et al.
International Journal of Molecular Sciences, 2023
Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro.
Zou LL et al.
Frontiers in Pharmacology, 2023
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform.
Kim B et al.
Translational and Clinical Pharmacology, 2021
Impact of peripheral mutations on the access channels of human cytochrome P450 1A2.
Ying B et al.
Journal of Biomolecular Structure & Dynamics, 2020
The molecular landscape of ETMR at diagnosis and relapse.
Lambo S et al.
Nature, 2019
Research/review: Insights into the mutation-induced dysfunction of arachidonic acid metabolism from modeling of human CYP2J2.
Xia XL et al.
Current Drug Metabolism, 2014
Advances in molecular modeling of human cytochrome P450 polymorphism.
Martiny VY et al.
Journal of Molecular Biology, 2013
Structural basis for the mutation-induced dysfunction of human CYP2J2: a computational study.
Cong S et al.
Journal of Chemical Information and Modeling, 2013
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
Zanger UM et al.
Pharmacology & Therapeutics, 2013
Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
Liu PY et al.
Atherosclerosis, 2007
Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma.
Polonikov AV et al.
Chest, 2007
CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study.
Lee CR et al.
Pharmacogenetics and Genomics, 2007
Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity.
Lee SS et al.
Pharmacogenetics and Genomics, 2005
Genetic polymorphisms, drug metabolism and drug concentrations.
Shenfield GM
The Clinical Biochemist. Reviews, 2004
Cytochrome P450 2J2 polymorphism in healthy Caucasians and those with diabetes mellitus.
Pucci L et al.
American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice, 2003
Cloning of CYP2J2 gene and identification of functional polymorphisms.
King LM et al.
Molecular Pharmacology, 2002